NZMA Home

Table of contents
Current issue
Search journal
Archived issues
NZMJ Obituaries 1887-2008
Classifieds
Hotline (free ads)
How to subscribe
How to contribute
How to advertise
Contact Us
Copyright
Other journals
The New Zealand Medical Journal

 Journal of the New Zealand Medical Association, 02-June-2006, Vol 119 No 1235

Cutaneous paraneoplastic syndrome (acrokeratosis paraneoplastica) preceding squamous cell carcinoma of the glottic larynx
Gorkem Aksu, Ahmet Karadeniz
Abstract
Paraneoplastic syndromes that occur in the minority of cancer patients are the produced signs and symptoms at distant sites from the tumour or its metastases. These syndromes may occur due to the production of substances by tumoural lesions that directly or indirectly cause distant symptoms or depletion of normal substances or host response to the tumours. A paraneoplastic syndrome may be the first sign of a malignancy so its recognition may be critical for early cancer detection. Most of the paraneoplastic syndromes associated with head and neck tumours are endocrinologic or neurologic; dermatologic syndromes are less common. Head and neck cancers also have occasionally been reported in association with paraneoplastic syndromes and to date there are only a few cases in the literature about the presence of a cutaneous paraneoplastic syndrome as the first manifestation of a laryngeal cancer, especially glottic larynx cancer. A wide variety of cutaneous syndromes are associated with malignancies and these syndromes may precede, follow, or be concurrent with the underlying malignancy.
In this report we present a case with cutaneous syndrome of acrokeratosis paraneoplastica preceding squamous cell carcinoma of glottic larynx, and review the other cutaneous paraneoplastic syndromes reported in the literature.

Paraneoplastic syndromes that occur in the minority of cancer patients are the produced signs and symptoms at distant sites from the tumour or its metastases. These syndromes may occur due to the production of substances by tumoural lesions that directly or indirectly cause distant symptoms or depletion of normal substances or host response to the tumours.
The best characterised paraneoplastic syndromes are those producing ectopic hormones such as parathyroid hormone (PTH) or adrenocorticotropin (ACTH)—in such cases the treatment of the underlying malignancy leads to the disappearance of the hormone and the syndrome.1–3
A paraneoplastic syndrome may be the first sign of a malignancy, so its recognition may be critical for early cancer detection. Also, the secreted proteins that cause paraneoplastic syndromes can be used as tumour markers during the therapy and follow-up for the evaluation of treatment response or recurrence.2,3
Head and neck cancers have occasionally been reported in association with paraneoplastic syndromes and to date there are only a few cases in the literature about the presence of a paraneoplastic syndrome as the first manifestation of a laryngeal cancer.1,4–6
In this report we present a case in which cutaneous paraneoplastic syndromes preceded the histopathological diagnosis of glottic laryngeal carcinoma, and we review the literature.

Case report

A 62-year-old man with a 35-pack per year smoking history referred to dermatology department of our hospital for skin lesions developing 3 months previously. On physical examination, hyperkeratotic psoriasiform plaques were present in both of his hands and soles. Both of the dorsal and palmar aspects of the fingers and nail folds were involved and his toenails were also thickened and dystrophic (Figure 1).
Figure 1. Hyperkeratotic psoriasiform plaques on the left hand of our case
Laboratory findings were within normal limits, and the only abnormal finding in physical examination (except skin lesions) was significant voice hoarseness. The patient claimed that skin lesions had preceded voice hoarseness. With these findings, an endoscopic examination of larynx was performed that showed a tumoural lesion in the left posterior ventricle extending up to the vocal cord.
A biopsy was taken from the lesion and the histopathological diagnosis was squamous cell carcinoma of the larynx. Computed tomography (CT) showed that the lesion was limited to the glottic region and there was no lymphadenopaties in the neck. CT of chest also demonstrated no pathology.
The patient was diagnosed as having glottic larynx cancer and acrokeratosis paraneoplastica, and he was treated with 66 Gy external radiotherapy with 2 Gy daily fractions. The skin lesions (except the nail dystrophy) significantly resolved after the completion of radiotherapy, and the patient is still alive 3 years later with no evidence of disease.

Discussion

A wide variety of cutaneous syndromes are associated with malignancies. These syndromes may precede, follow, or be concurrent with the underlying malignancy. The most critical point is that once a potential cutaneous paraneoplastic syndrome has been diagnosed, an extensive systemic evaluation emphasising the malignancies most strongly associated with that type skin lesion shall be undertaken.
The physicians especially should be aware of some cutaneous lesions that are uncommon and usually associated with cancer.1,2 Acrokeratosis paraneoplastica is a typical example of such lesions since it is one of the most rare cutaneous paraneoplastic syndromes and is typically present in patients with squamous cell carcinoma of the oesophagus, head, and neck or lungs. The eruptive lesions are characteristically hyperkeratosic, resembling psoriasis and favouring acral sites and nails.
In most of cases, including ours, acrokeratosis paraneoplastica is the first sign of the underlying occult malignancy. Antigenic cross-reaction of basement membrane and tumour antigens, and the secretion of some growth factors such as insulin-like growth factor-1 (ILGF-1) or transforming growth factor-alpha (TGF-alpha), are thought to be possible mechanisms causing this syndrome—as squamous cell carcinomas have been shown to synthesise and secrete these autoimmune growth factors.6–9
Head and neck squamous cell carcinomas are the most frequently associated malignancy with this syndrome, and oropharynx or larynx cancers make up more than 60% of the cases reported in the literature.8,9 Bazex described three stages for cutaneous lesions of acrokeratosis paraneoplastica; he reported that fingers, toes, soles, and (in some cases) the ear helices and nose are affected usually in a symmetrical fashion.
Bazex also mentioned that the average time between the appearance of the cutaneous lesions and the detection of the underlying tumour is about 11 months, but this interval is shorter in some of the reported cases in the literature, including our case.10 The skin eruptions may resolve with the treatment of underlying malignancy but in some cases the lesions persist or reappear with the recurrence of the tumour. UV-A phototherapy or retinoids and oral psoralen have been used in some cases with the reportage of limited benefits.7–9
Seborrheic keratosis which is generally seen in elderly patients can also appear as a paraneoplastic cutaneous syndrome. The Leser-Trelat sign which is characterised by the sudden appearance and rapid increase in the number and size of seborrheic keratoses is important since these lesions can be associated with internal malignancies. The most common malignancy is adenocarcinoma of the stomach but the syndrome can also be present in patients with breast cancer as well as squamous cell carcinomas of head, neck, and lung.8,10
As described above, early diagnoses of these lesions is critical because, with our case, these cutaneous lesions may precede or be concurrent with an underlying malignancy. Therefore paying careful attention to such lesions may lead earlier detection of at least some malignancies.
Author information: Gorkem Aksu, Assistant Professor, Faculty of Medicine, Radiation Oncology Department, Kocaeli University, Kocaeli; Ahmet Karadeniz, Professor, Radiation Oncology Department, Oncology Institute, Istanbul University; Turkey
Correspondence: Gorkem Aksu, Yahyakaptan Mahallesi, F 29 Blok, Daire: 12, Yahyakaptan, Kocaeli, Turkey. Fax: +90 262 3038003; email: aksugorkem@yahoo.com
References:
  1. Kurzrock R, Cohen PR: Cutaneous paraneoplastic syndromes in solid tumors. Am J Medicine. 1995;99:662–71.
  2. Callen J. Dermatologic signs of systemic diseases. In: Bologna J, Jorizzo J, Rapini R, editors. Dermatology. St Louis: Mosby; 2003, p712–3 [chapter 53].
  3. Dalmau J, Posner B: Paraneoplastic syndromes. Arch Neurol. 1995;56:405–8.
  4. Ferlito A, Rinaldo A. Clinopathological consultation. Paraneoplastic syndromes in patients with laryngeal and hypopharyngeal cancers. Ann Otol Rhinol Laryngol. 2000;109:109–17.
  5. Bataller L, Dalmau JO. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol. 2004;24:461–71.
  6. Viteri A, Munoz A, Barcelo R. Acrokeratosis paraneoplastica (Bazex Syndrome) preceeding the diagnosis of metastatic squamous cell carcinoma of the esophagus. J Am Acad Dermatol. 2005;52:711–2.
  7. Valdivielso M, Longo I, Suarez R, et al. Acrokeratosis paraneoplastica: Bazex Syndrome. J Eur Acad Dermatol Venereol. 2005;19:340–4.
  8. Wareing MJ, Vaughan-Jones SA, McGibbon DH: Acrokeratosis paraneoplastica: Bazex syndrome. J Laryngol Otol. 1996;110:899–900.
  9. Sarkar B, Knecht R, Sarkar C, Weidauer H. Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol. 1998;255:205–10.
  10. Bazex A, Griffiths A. Acrokeratosis paraneoplastica—a new cutaneous marker for malignancy. Br J Dermatol. 1980;103:301–6.
     
Current issue | Search journal | Archived issues | Classifieds | Hotline (free ads)
Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals